Rising Concerns over Animal Health across Europe to Boost the Veterinary Vaccines Market

The Europe Veterinary Vaccines Market is expecting around 5.5% CAGR during 2021-26, cites MarkNtel Advisors in their recent research report. The increasing inclination of people toward animal companionship is projecting a substantial hike in pet ownership across Europe, i.e., the prime aspect propelling the demand for veterinary vaccines and driving the market.

Moreover, with an exponentially rising population, the demand for animal-derived food is mounting swiftly across different countries in Europe and surging the need for veterinary vaccines to avoid diseases in animals & attain healthy food, thereby driving the market.

Furthermore, the swiftly increasing inclination of several animal care associations & massive investments by the leading players in developing these vaccines for animals is another prominent aspect projected to contribute to the overall market growth in the years to come, further states the research report, “Europe Veterinary Vaccines Market Analysis, 2021.”

Mounting Focus on Strengthening Immunity Spurs the Demand for Live Attenuated Vaccines

Live Attenuated vaccines acquired the largest share in the Europe Veterinary Vaccines Market in the previous few years. It attributes principally to the mounting awareness about the benefits of these vaccines to enable the immune system in activating effective cellular & antibody responses and facilitate life-long immunity against infectious pathogens with just one or two doses. Moreover, live attenuated vaccines help minimize the need for booster vaccines that can be administered orally and generates long-lasting & rapid onset of immunity, i.e., another crucial aspect positively contributing to the overall market growth.

Rising Vaccine Production in France to Significantly Boost the Market through 2026

Of all countries across Europe, France is expecting the fastest market growth during 2021-26. It owes principally to the growing pet ownership in the country, coupled with the active participation of the leading market players in producing vaccines abiding closely by norms specified by the European Pharmacopeia & OIE (Office International des Epizooties) and meeting the requirements. Moreover, the rapid rise in instances of zoonotic diseases is instigating prominent vaccine manufacturers to expand their production capacities to meet the burgeoning end-user needs. It, in turn, would also create lucrative growth opportunities for the market across France in the coming years, states MarkNtel Advisors in their research report, "Europe Veterinary Vaccines Market Analysis, 2021."

Competitive Landscape:

The leading players in the Europe Veterinary Vaccines Market include Merck & Co. Inc., Virbac SA, Elanco Animal Health, Ceva Sante Animale, Phibro Animal Health Corp., HIPRA, Zoetis Inc., Boehringer Ingelheim International GmbH, & Neogen Corporation.

Key Questions Answered in the Research Report:

1. What are the current & future trends in the Europe Veterinary Vaccines Market?
2. How has the industry been evolving in terms of geography & product adoption?
3. How has the competition been shaping across Europe, followed by their comparative factorial indexing?
4. What are the key growth drivers & challenges for the Europe Veterinary Vaccines Market?
5. What are the customer orientation, purchase behavior, & expectations from veterinary vaccine manufacturers across Europe?

Market Segmentation:

1. By Animal Vaccine Type (Livestock Vaccines (Bovine Vaccines, Poultry Vaccines, Porcine Vaccines), Companion Animal Vaccines (Canine Vaccines, Feline Vaccines, Equine Vaccines))
2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other (DNA Vaccines, Subunit Vaccines, Conjugate Vaccines))
3. By Disease Type (Canine Disease (Distemper, Kennel cough (Parainfluenza), Parvovirus, Canine herpes, Lyme Disease, Rabies), Porcine Disease, Bovine Disease (Foot & mouth disease (FMD), Lumpy skin, Rotavirus, Coronavirus, E. Coli), Poultry Disease (Infectious Bronchitis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella), Aquaculture Disease (Streptococcosis, Vibrio, Aeromonas))
4. By Country (The UK, Germany, Italy, France, Spain)
5. By Competitors (Merck & Co. Inc., Virbac SA, Elanco Animal Health, Ceva Sante Animale, Phibro Animal Health Corp., HIPRA, Zoetis Inc., Boehringer Ingelheim International GmbH, Neogen Corporation)